Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of pediatric hematology/oncology

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00043426-200307000-00017PMID 12847329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].

  2001cited by this paper
• Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.

  2001influential reference
• A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.

  2001cited by this paper
• Resultados del tratamiento con 2-clorodesoxiadenosina en la histiocitosis de células de Langerhans resistente o en recaída. Estudio de 9 pacientes

  2001cited by this paper
• Thickened Pituitary Stalk on Magnetic Resonance Imaging in Children with Central Diabetes insipidus

  2000influential reference
• Cladribine activity in adult langerhans-cell histiocytosis.

  1999cited by this paper
• Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

  1999cited by this paper
• Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.

  1999cited by this paper
• Langerhans cell histiocytosis

  1999cited by this paper
• Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?

  1997cited by this paper
• Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus.

  1997cited by this paper
• Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?

  1997influential reference
• Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study.

  1995influential reference
• Langerhans' Cell Histiocytosis of the Head and Neck in Children

  1995cited by this paper
• The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.

  1989cited by this paper

• Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis

  2021cites this paper
• Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System

  2021cites this paper
• Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China

  2020cites this paper
• Cladribine in the Treatment of Langerhans Cell Histiocytosis: A Summary of the Literature

  2019cites this paper
• Late Effects of Langerhans Cell Histiocytosis and the Association of LCH with Malignancy

  2018cites this paper
• Treatment of Relapsed and Refractory Langerhans Cell Histiocytosis in Children

  2018cites this paper
• A case report and review of literature

  2018cites this paper
• Laryngeal Langerhans Cell Histiocytosis Presenting with Neck Mass in an Adult Woman

  2016cites this paper
• Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.

  2016cites this paper
• Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.

  2015cites this paper
• Essential hypernatremia: evidence of reset osmostat in the absence of demonstrable hypothalamic lesions.

  2014cites this paper
• Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases

  2013cites this paper
• Reversal of LCH‐related diabetes insipidus and reappearance of posterior pituitary bright spot with low‐dose chemotherapy

  2012cites this paper
• Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years

  2012cites this paper
• Langerhans' Cell Histiocytosis of the Central Nervous System

  2012cites this paper
• Medical management of langerhans cell histiocytosis from diagnosis to treatment

  2012cites this paper
• Management of Langerhans Cell Histiocytosis (LCH)-Induced Central Diabetes Insipidus and Its Associated Endocrinological/Neurological Sequelae

  2011cites this paper
• Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan

  2011cites this paper
• Langerhans cell histiocytosis: old disease new treatment.

  2011cites this paper
• Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis

  2011cites this paper
• Central nervous system disease in Langerhans cell histiocytosis.

  2010cites this paper
• Langerhans cell histiocytosis: Current concepts and treatments.

  2010cites this paper
• L Central Nervous System Disease in Langerhans Cell Histiocytosis

  2010cites this paper
• Acquired Disorders of the Hypothalamo-Pituitary Axis

  2010cites this paper
• High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.

  2009cites this paper
• Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?

  2009cites this paper
• Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosine

  2008cites this paper
• ! review of Langerhans' cell hystiocitosis Review Article

  2008cites this paper
• Langerhans cell histiocytosis: a review of past, current and future therapies.

  2007cites this paper
• [Thalidomide in adult multisystem Langerhans cell histiocytosis: a case report].

  2006cites this paper
• Efficacité du thalidomide dans le traitement de l'histiocytose langerhansienne multisystémique de l'adulte : à propos d'une observation

  2006cites this paper
• Langerhans cell histiocytosis

  2006cites this paper
• Risk factors for diabetes insipidus in langerhans cell histiocytosis

  2006cites this paper
• Spontaneous Gonadotrophin Deficiency Recovery in an Adult Patient with Langerhans Cell Histiocytosis (LCH)

  2005cites this paper
• Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children.

  2005cites this paper
• Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

  2005cites this paper
• Drug therapy for the treatment of Langerhans cell histiocytosis

  2005cites this paper